Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Profound Medical Corp (PRN.TO)

Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 362,558
  • Shares Outstanding, K 35,372
  • Annual Sales, $ 10,680 K
  • Annual Income, $ -27,816 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.91
  • Price/Sales 15.21
  • Price/Cash Flow N/A
  • Price/Book 8.24
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.32
  • Most Recent Earnings $-0.26 on 11/13/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-8071 Services-Medical Laboratories

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.42
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.55 +15.20%
on 12/02/25
10.91 -9.72%
on 12/18/25
+0.77 (+8.48%)
since 11/28/25
3-Month
6.73 +46.36%
on 10/02/25
10.91 -9.72%
on 12/18/25
+2.76 (+38.93%)
since 09/29/25
52-Week
5.23 +88.34%
on 09/10/25
11.45 -13.97%
on 01/02/25
-0.38 (-3.71%)
since 12/27/24

Most Recent Stories

More News
Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the closing of its previously announced registered direct...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Reports Strong Third Quarter 2025 Financial Results

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered,...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered,...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East All required...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...

PRN.TO : 9.92 (-3.22%)
PROF : 7.29 (-1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure....

See More

Key Turning Points

3rd Resistance Point 10.80
2nd Resistance Point 10.57
1st Resistance Point 10.41
Last Price 9.92
1st Support Level 10.02
2nd Support Level 9.79
3rd Support Level 9.63

See More

52-Week High 11.45
Last Price 9.92
Fibonacci 61.8% 9.07
Fibonacci 50% 8.34
Fibonacci 38.2% 7.61
52-Week Low 5.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar